Journal of Neurogastroenterology and Motility

  • 제24권4호
  • /
  • Pages.656-668
  • /
  • 2018
  • /
  • 2093-0879(pISSN)
  • /
  • 2093-0887(eISSN)
대한소화기 기능성질환 운동학회 (The Korean Society of Neurogastroenterology and Motility)
권호 표지
DOI QR코드

DOI QR Code

MicroRNA-200a Targets Cannabinoid Receptor 1 and Serotonin Transporter to Increase Visceral Hyperalgesia in Diarrhea-predominant Irritable Bowel Syndrome Rats

  • Hou, Qiuke (Department of Gastroenterology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine) ;
  • Huang, Yongquan (Department of Orthopedics, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine) ;
  • Zhang, Changrong (Department of Gastroenterology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine) ;
  • Zhu, Shuilian (Department of Gastroenterology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine) ;
  • Li, Peiwu (Department of Gastroenterology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine) ;
  • Chen, Xinlin (Department of Preventive Medicine and Health Statistics, Guangzhou University of Chinese Medicine) ;
  • Hou, Zhengkun (Department of Gastroenterology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine) ;
  • Liu, Fengbin (Department of Gastroenterology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine)
  • 투고 : 2018.03.03
  • 심사 : 2018.07.12
  • 발행 : 2018.10.30
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims MicroRNAs (miRNAs) were reported to be responsible for intestinal permeability in diarrhea-predominant irritable bowel syndrome (IBS-D) rats in our previous study. However, whether and how miRNAs regulate visceral hypersensitivity in IBS-D remains largely unknown. Methods We established the IBS-D rat model and evaluated it using the nociceptive visceral hypersensitivity test, myeloperoxidase activity assay, restraint stress-induced defecation, and electromyographic (EMG) activity. The distal colon was subjected to miRNA microarray analysis followed by isolation and culture of colonic epithelial cells (CECs). Bioinformatic analysis and further experiments, including dual luciferase assays, quantitative real-time polymerase chain reaction, western blot, and enzyme-linked immunosorbent assay, were used to detect the expression of miRNAs and how it regulates visceral hypersensitivity in IBS-D rats. Results The IBS-D rat model was successfully established. A total of 24 miRNAs were differentially expressed in the distal colon of IBS-D rats; 9 were upregulated and 15 were downregulated. Among them, the most significant upregulation was miR-200a, accompanied by downregulation of cannabinoid receptor 1 (CNR1) and serotonin transporter (SERT). MiR-200a mimic markedly inhibited the expression of CNR1/SERT. Bioinformatic analysis and luciferase assay confirmed that CNR1/SERT are direct targets of miR-200a. Rescue experiments that overexpressed CNR1/SERT significantly abolished the inhibitory effect of miR-200a on the IBS-D rats CECs. Conclusions This study suggests that miR-200a could induce visceral hyperalgesia by targeting the downregulation of CNR1 and SERT, aggravating or leading to the development and progression of IBS-D. MiR-200a may be a regulator of visceral hypersensitivity, which provides potential targets for the treatment of IBS-D.

키워드

과제정보

연구 과제 주관 기관 : China Postdoctoral Science Foundation, Chinese Medicine Science Research Project of Guangdong Province

참고문헌

  1. Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology 2016;150:1257-1261. https://doi.org/10.1053/j.gastro.2016.03.035
  2. Oshima T, Miwa H. Epidemiology of functional gastrointestinal disorders in Japan and in the world. J Neurogastroenterol Motil 2015;21:320-329. https://doi.org/10.5056/jnm14165
  3. Asano T, Tanaka KI, Tada A, et al. Aminophylline suppresses stressinduced visceral hypersensitivity and defecation in irritable bowel syndrome. Sci Rep 2017;7:40214. https://doi.org/10.1038/srep40214
  4. Chen MX, Chen Y, Fu R, Liu SY, Yang QQ, Shen TB. Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats. Am J Transl Res 2016;8:5580-5590.
  5. Camilleri M. Is there a SERT-ain association with IBS? Gut 2004;53:1396-1399. https://doi.org/10.1136/gut.2004.039826
  6. Jiang Y, Nie Y, Li Y, Zhang L. Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome. J Gastroenterol Hepatol 2014;29:1186-1191. https://doi.org/10.1111/jgh.12513
  7. Storr M, Emmerdinger D, Diegelmann J, et al. The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease. PLoS One 2010;5:e9453. https://doi.org/10.1371/journal.pone.0009453
  8. Abalo R, Chen C, Vera G, et al. In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat. Neurogastroenterol Motil 2015;27:1721-1735. https://doi.org/10.1111/nmo.12668
  9. McKenna LB, Schug J, Vourekas A, et al. MicroRNAs control intestinal epithelial differentiation, architecture, and barrier function. Gastroenterology 2010;139:1654-1664, 1664, e1. https://doi.org/10.1053/j.gastro.2010.07.040
  10. O'Hara SP, Mott JL, Splinter PL, Gores GJ, LaRusso NF. MicroRNAs: key modulators of posttranscriptional gene expression. Gastroenterology 2009;136:17-25. https://doi.org/10.1053/j.gastro.2008.11.028
  11. Kalla R, Ventham NT, Kennedy NA. MicroRNAs: new players in inflammatory bowel disease. Gut 2015;64:1008. https://doi.org/10.1136/gut.2014.307891corr1
  12. Zhang L, Cheng J, Fan XM. MicroRNAs: new therapeutic targets for intestinal barrier dysfunction. World J Gastroenterol 2014;20:5818-5825. https://doi.org/10.3748/wjg.v20.i19.5818
  13. Wu F, Zikusoka M, Trindade A, et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008;135:1624-1635, e24. https://doi.org/10.1053/j.gastro.2008.07.068
  14. Neesse A, Gress TM. Emerging role of microRNAs to tackle drug resistance in pancreatic cancer. Gut 2015;64:1842-1843. https://doi.org/10.1136/gutjnl-2015-309503
  15. Kalla R, Ventham NT, Kennedy NA, et al. MicroRNAs: new players in IBD. Gut 2015;64:504-517. https://doi.org/10.1136/gutjnl-2014-307891
  16. Nguyen HT, Dalmasso G, Muller S, Carriere J, Seibold F, Darfeuille-Michaud A. Crohn's disease-associated adherent invasive Escherichia coli modulate levels of microRNAs in intestinal epithelial cells to reduce autophagy. Gastroenterology 2014;146:508-519. https://doi.org/10.1053/j.gastro.2013.10.021
  17. Hou Q, Huang Y, Zhu S, et al. MiR-144 increases intestinal permeability in IBS-D rats by targeting OCLN and ZO1. Cell Physiol Biochem 2017;44:2256-2268. https://doi.org/10.1159/000486059
  18. Sun J, Wu X, Meng Y, et al. Electro-acupuncture decreases 5-HT, CGRP and increases NPY in the brain-gut axis in two rat models of diarrhea-predominant irritable bowel syndrome (D-IBS). BMC Complement Altern Med 2015;15:340. https://doi.org/10.1186/s12906-015-0863-5
  19. Zhou Q, Price DD, Dreher KL, et al. Localized colonic stem cell transplantation enhances tissue regeneration in murine colitis. J Cell Mol Med 2012;16:1900-1915. https://doi.org/10.1111/j.1582-4934.2011.01485.x
  20. Winston J, Shenoy M, Medley D, Naniwadekar A, Pasricha PJ. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology 2007;132:615-627. https://doi.org/10.1053/j.gastro.2006.11.014
  21. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-1350. https://doi.org/10.1016/0016-5085(84)90202-6
  22. Booth C, Patel S, Bennion GR, Potten CS. The isolation and culture of adult mouse colonic epithelium. Epithelial Cell Biol 1995;4:76-86.
  23. Ren HX, Zhang FC, Luo HS, Zhang G, Liang LX. Role of mast cell-miR-490-5p in irritable bowel syndrome. World J Gastroenterol 2017;23:93-102. https://doi.org/10.3748/wjg.v23.i1.93
  24. Zhou Q, Verne GN. miRNA-based therapies for the irritable bowel syndrome. Expert Opin Biol Ther 2011;11:991-995. https://doi.org/10.1517/14712598.2011.577060
  25. Fourie NH, Peace RM, Abey SK, et al. Elevated circulating miR-150 and miR-342-3p in patients with irritable bowel syndrome. Exp Mol Pathol 2014;96:422-425. https://doi.org/10.1016/j.yexmp.2014.04.009
  26. Koukos G, Polytarchou C, Kaplan JL, et al. A microRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium. Inflamm Bowel Dis 2015;21:996-1005. https://doi.org/10.1097/MIB.0000000000000339
  27. Zhou Q, Costinean S, Croce CM, et al. MicroRNA 29 targets nuclear factor-${\kappa}B$-repressing factor and claudin 1 to increase intestinal permeability. Gastroenterology 2015;148:158-169, e8. https://doi.org/10.1053/j.gastro.2014.09.037
  28. Zhou Q, Yang L, Larson S, et al. Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Gut 2016;65:797-805. https://doi.org/10.1136/gutjnl-2013-306464
  29. Liao XJ, Mao WM, Wang Q, Yang GG, Wu WJ, Shao SX. MicroRNA-24 inhibits serotonin reuptake transporter expression and aggravates irritable bowel syndrome. Biochem Biophys Res Commun 2016;469:288-293. https://doi.org/10.1016/j.bbrc.2015.11.102
  30. Baudry A, Mouillet-Richard S, Schneider B, Launay JM, Kellermann O. miR-16 targets the serotonin transporter: a new facet for adaptive responses to antidepressants. Science 2010;329:1537-1541. https://doi.org/10.1126/science.1193692
  31. Vianna CR, Donato J Jr, Rossi J, et al. Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility. J Neurosci 2012;30:10331-10337.
  32. Hong S, Fan J, Kemmerer ES, Evans S, Li Y, Wiley JW. Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed rat. Gut 2009;58:202-210. https://doi.org/10.1136/gut.2008.157594
  33. Hong S, Zheng G, Wiley JW. Epigenetic regulation of genes that modulate chronic stress-induced visceral pain in the peripheral nervous system. Gastroenterology 2015;148:148-157, e7. https://doi.org/10.1053/j.gastro.2014.09.032
  34. Reigstad CS, Linden DR, Szurszewski JH, Sonnenburg JL, Farrugia G, Kashyap PC. Correlated gene expression encoding serotonin (5-HT) receptor 4 and 5-HT transporter in proximal colonic segments of mice across different colonization states and sexes. Neurogastroenterol Motil 2016;28:1443-1448. https://doi.org/10.1111/nmo.12840
  35. Gutierrez B, Bellon JA, Rivera M, et al. The risk for major depression conferred by childhood maltreatment is multiplied by BDNF and SERT genetic vulnerability: a replication study. J Psychiatry Neurosci 2015;40:187-196. https://doi.org/10.1503/jpn.140097
  36. Wolmarans de W, Brand L, Stein DJ, Harvey BH. Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessivecompulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density. Behav Brain Res 2013;256:545-553. https://doi.org/10.1016/j.bbr.2013.08.049
  37. Charoenphandhu J, Teerapornpuntakit J, Nuntapornsak A, Krishnamra N, Charoenphandhu N. Anxiety-like behaviors and expression of SERT and TPH in the dorsal raphe of estrogen- and fluoxetine-treated ovariectomized rats. Pharmacol Biochem Behav 2011;98:503-510. https://doi.org/10.1016/j.pbb.2011.02.023
  38. Cui XF, Zhou WM, Yang Y, et al. Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome. World J Gastroenterol 2014;37:13521-13529.
  39. Sikander A, Rana SV, Sinha SK, et al. Serotonin transporter promoter variant: analysis in Indian IBS patients and control population. J Clin Gastroenterol 2009;43:957-961. https://doi.org/10.1097/MCG.0b013e3181b37e8c
  40. Galligan JJ, Patel BA, Schneider SP, et al. Visceral hypersensitivity in female but not in male serotonin transporter knockout rats. Neurogastroenterol Motil 2013;25:e373-e381. https://doi.org/10.1111/nmo.12133

Cited by

  1. What’s in the pipeline for lower functional gastrointestinal disorders in the next 5 years? vol.317, pp.5, 2018, https://doi.org/10.1152/ajpgi.00205.2019
  2. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways vol.19, pp.1, 2018, https://doi.org/10.1186/s12906-019-2749-4
  3. Epigenetic Mechanisms in Irritable Bowel Syndrome vol.11, pp.None, 2020, https://doi.org/10.3389/fpsyt.2020.00805
  4. Serotonin transporter untranslated regions influence mRNA abundance and protein expression vol.18, pp.None, 2020, https://doi.org/10.1016/j.genrep.2019.100513
  5. microRNA‐495 reduces visceral sensitivity in mice with diarrhea‐predominant irritable bowel syndrome through suppression of the PI3K/AKT signaling pathway via PKIB vol.72, pp.7, 2018, https://doi.org/10.1002/iub.2270
  6. Micro-organic basis of functional gastrointestinal (GI) disorders: Role of microRNAs in GI pacemaking cells vol.40, pp.2, 2018, https://doi.org/10.1007/s12664-021-01159-7
  7. The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p, and MicroRNA-338-3p Are Downregulated in Irritable Bowel Syndrome and Are Associated With Barrier Function and MAPK Signaling vol.160, pp.7, 2018, https://doi.org/10.1053/j.gastro.2021.02.040
  8. Role of microRNAs in Disorders of Gut-Brain Interactions: Clinical Insights and Therapeutic Alternatives vol.11, pp.10, 2018, https://doi.org/10.3390/jpm11101021
  9. Regulation of serum microRNA expression by acupuncture in patients with diarrhea-predominant irritable bowel syndrome vol.40, pp.1, 2022, https://doi.org/10.1177/09645284211027892